Vitreo-Retinal Associates, Michigan Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01473251
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Louis C. Glazer, MD | Vitreo Retinal Associates | Vitreo-Retinal Associates | Vitreo-Retinal Associates, Michigan | Vitreo-Retinal Associates, PC